CEMIPLIMAB

UNII: 6QVL057INT
Preferred Substance Name: CEMIPLIMAB

1801342-60-8
CEMIPLIMAB [INN]
CEMIPLIMAB [JAN]
CEMIPLIMAB [MI]
CEMIPLIMAB [USAN]
CEMIPLIMAB [WHO-DD]
CEMIPLIMAB RWLC [WHO-DD]
CEMIPLIMAB-RWLC
CEMIPLIMAB-RWLC [PURPLE BOOK CDER]
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
LIBTAYO
REGN2810
REGN-2810

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

CEMIPLIMAB

Synonyms and Mappings

Resources

Note